Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) — Financial Flexibility Index
Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a Financial Flexibility Index of 0.01x as of September 2025. Free cash flow of CN¥19.91 Million (operating CF CN¥-15.07 Million minus capex CN¥34.98 Million) represents 0% of total liabilities (CN¥2.37 Billion). Check Jiangsu Lianhuan Pharmaceutical Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jiangsu Lianhuan Pharmaceutical Co Ltd Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for Jiangsu Lianhuan Pharmaceutical Co Ltd across 23 annual periods. See working capital to net assets of Jiangsu Lianhuan Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)
Year-by-year free cash flow to debt coverage for Jiangsu Lianhuan Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of Jiangsu Lianhuan Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.14x | CN¥195.61 Million | CN¥10.77 Million | CN¥1.44 Billion | ▼ -49.8% |
| 2023 | 0.27x | CN¥361.37 Million | CN¥160.70 Million | CN¥1.34 Billion | ▲ +4.4% |
| 2022 | 0.26x | CN¥336.61 Million | CN¥127.59 Million | CN¥1.30 Billion | ▼ -9.6% |
| 2021 | 0.29x | CN¥307.27 Million | CN¥138.34 Million | CN¥1.07 Billion | ▼ -6.8% |
| 2020 | 0.31x | CN¥266.12 Million | CN¥91.94 Million | CN¥867.05 Million | ▲ +55.7% |
| 2019 | 0.20x | CN¥158.76 Million | CN¥-9.87 Million | CN¥805.57 Million | ▲ +156.6% |
| 2018 | 0.08x | CN¥36.36 Million | CN¥-92.00 Million | CN¥473.43 Million | ▼ -57.9% |
| 2017 | 0.18x | CN¥52.28 Million | CN¥3.64 Million | CN¥286.25 Million | ▼ -62.5% |
| 2016 | 0.49x | CN¥116.50 Million | CN¥70.28 Million | CN¥239.03 Million | ▲ +22.8% |
| 2015 | 0.40x | CN¥89.53 Million | CN¥62.12 Million | CN¥225.66 Million | ▼ -4.0% |
| 2014 | 0.41x | CN¥92.87 Million | CN¥69.50 Million | CN¥224.71 Million | ▲ +50.3% |
| 2013 | 0.27x | CN¥68.02 Million | CN¥37.17 Million | CN¥247.36 Million | ▲ +9.8% |
| 2012 | 0.25x | CN¥23.24 Million | CN¥16.94 Million | CN¥92.79 Million | ▼ -47.0% |
| 2011 | 0.47x | CN¥42.98 Million | CN¥24.00 Million | CN¥90.91 Million | ▲ +133.1% |
| 2010 | 0.20x | CN¥18.69 Million | CN¥8.43 Million | CN¥92.13 Million | ▼ -33.1% |
| 2009 | 0.30x | CN¥27.12 Million | CN¥13.83 Million | CN¥89.47 Million | ▼ -50.4% |
| 2008 | 0.61x | CN¥47.69 Million | CN¥17.44 Million | CN¥77.98 Million | ▲ +142.5% |
| 2007 | 0.25x | CN¥22.11 Million | CN¥8.03 Million | CN¥87.69 Million | ▼ -57.4% |
| 2006 | 0.59x | CN¥45.34 Million | CN¥10.14 Million | CN¥76.64 Million | ▲ +77.6% |
| 2005 | 0.33x | CN¥16.47 Million | CN¥3.82 Million | CN¥49.44 Million | ▲ +137.8% |
| 2004 | 0.14x | CN¥8.63 Million | CN¥3.39 Million | CN¥61.63 Million | ▲ +318.4% |
| 2003 | -0.06x | CN¥-3.01 Million | CN¥-13.19 Million | CN¥46.99 Million | ▼ -110.4% |
| 2002 | 0.61x | CN¥25.19 Million | CN¥19.22 Million | CN¥41.02 Million | — |